How Much Does an eCOA and ePRO Platform Cost in 2026?

What an eCOA build costs, and what sits outside the build

Across the patient-facing outcomes work Digital Heroes has delivered for sponsors and digital health teams, a first release runs $95,000 to $200,000 and ships in 14 to 20 weeks. That release renders instruments faithfully, schedules diary windows, captures entries with no connectivity, reminds patients, shows sites their own compliance, and keeps an audit trail that stands up. A full platform adding provisioned device fleet management, bring-your-own-device distribution, multi-language instrument versions, wearable and sensor ingestion, proxy reporting and an EDC reconciliation feed runs $280,000 to $650,000 across 9 to 15 months.

Two costs sit outside the software entirely and belong in the same budget conversation. Instrument licence fees are paid to whoever owns the copyright on the questionnaire, they are quoted per study by that owner, and they are the same whether you build or licence a platform. Screen-level migration approval is the other: moving a validated paper instrument to a screen usually requires the instrument owner to review and approve the electronic presentation, per instrument, per language, and sometimes per device form factor. That approval cycle is a calendar cost more than a cash one, and it is the most common reason an eCOA go-live date moves.

Scope band one: rendering, diaries, offline capture and compliance

Typical line items in a first release:

• Instrument rendering engine: $34,000 to $52,000. Instruments must appear as licensed and validated, with item order, response option layout, recall period wording and scale presentation preserved. This is not a form builder with a theme. Getting it wrong invalidates the endpoint, which is why it is the most expensive single line.
• Diary scheduling and windows: $22,000 to $36,000. Fixed windows, event-driven entries, grace periods and the rules that decide when an entry is late rather than missing.
• Offline capture and sync: $26,000 to $42,000. Patients complete diaries on aircraft, in basements and in rural areas. Entries must be timestamped at the moment of completion, not at the moment of sync, and that distinction is an endpoint integrity requirement rather than a nicety.
• Reminders and adherence prompts: $14,000 to $24,000. Configurable per study, per instrument and per patient preference, without becoming so insistent that patients disengage.
• Site compliance view: $16,000 to $28,000. Coordinators need to see which of their patients are drifting, early enough to intervene, without ever seeing responses they should not see.
• Part 11 audit trail: $18,000 to $30,000. A patient entry carries a completion time the patient must not be able to backdate, so the trail has to hold device clock, server clock and the drift between them alongside attribution and reason for change.

Scope band two: devices, languages and data integration

The second band runs $280,000 to $650,000. Provisioned device fleet management covers enrolment, kiosk lockdown, connectivity, retrieval and wipe at study end, and it is more logistics software than clinical software. Bring-your-own-device distribution has to work across a wide spread of hardware and operating system versions that you do not control, which is a testing matrix rather than a feature.

Multi-language instrument versioning is the line most sponsors underestimate. Each language of each instrument is a separate approved artifact, and a change to the source has to propagate correctly to every translation without any of them drifting. Add wearable and sensor ingestion for digital endpoints, proxy reporting for paediatric and cognitively impaired populations, and a reconciliation feed into EDC so outcomes data and clinical data agree, and this band fills quickly.

What pushes the cost up

• Language count. Every additional language multiplies rendering artifacts, testing and approval cycles. Eleven languages is not marginally harder than three, it is a different project.
• Bring-your-own-device. Supporting patient-owned hardware widens the test matrix considerably, and it introduces support cases you cannot reproduce because you do not have the device.
• Wearables and sensors. Continuous data alongside episodic diary entries needs its own ingestion, gap handling and reconciliation logic. Budget $50,000 to $85,000 for that capability.
• Paediatric and proxy reporting. A caregiver completing on behalf of a patient changes attribution, consent and audit trail requirements throughout.
• A strict quality function. As with any regulated system, validation scope is set by your QA group, and the same feature set can vary by $60,000 or more between two sponsors.

What brings the cost down

• Fewer languages at launch. Start with the languages your first two studies actually need and add the rest as the portfolio expands. This is the single most effective lever.
• Provisioned devices only for the first study. A controlled device fleet is more logistics work but far less testing work than bring-your-own-device, and it removes a large category of unreproducible support cases from your first release.
• Deferring wearables. If your primary endpoint is a questionnaire, sensor ingestion can wait for a study that actually needs it.
• Carrying forward instrument presentations already approved. Where a questionnaire has been approved on screen for an earlier study, reusing that exact presentation avoids a fresh migration review and the approval cycle attached to it.

A worked example that adds up

A sponsor running seven concurrent studies on a repeating instrument set across 160 sites, eleven languages and a mix of provisioned devices and patient-owned phones. First release, line by line:

• Discovery, instrument inventory and licensing review: $14,000
• Instrument rendering engine, screen-faithful to the validated presentation: $40,000
• Diary scheduling with windows and grace periods: $28,000
• Offline capture with completion-time stamping and sync: $32,000
• Reminders and adherence prompts: $18,000
• Site compliance view for coordinators: $20,000
• Part 11 audit trail: $22,000

That totals $174,000 and ships in about 18 weeks. Phase two adds provisioned device fleet management at roughly $60,000, bring-your-own-device distribution at roughly $45,000, multi-language instrument versioning across eleven languages at roughly $70,000, wearable and sensor ingestion at roughly $65,000, proxy reporting at roughly $30,000, the EDC reconciliation feed at roughly $40,000 and computerised system validation at roughly $85,000. That is $395,000, taking the platform to $569,000. Instrument licence fees and translation approvals sit on top and are paid to the instrument owners regardless of who builds the software.

Timeline and the approval cycle that governs it

Fourteen to twenty weeks of build, but the date that matters is the instrument owner's approval of your electronic presentation. Start that conversation in week one, not after the screens are finished, because approval cycles run on the copyright holder's calendar rather than yours and a rejected presentation means rework plus a second cycle. Sponsors who treat licensing and migration approval as a procurement task to handle later are the ones whose eCOA launch slips by a quarter, and it is almost never the code that caused it.

The compliance number that decides whether this was worth it

Every business case for eCOA eventually rests on one figure: the share of scheduled diary entries that arrive complete and inside their window. That number is what protects the endpoint, and it is the only honest measure of whether the platform earned its cost. Before funding a build, get your current figure from your existing studies and be specific about which studies and which instruments it came from.

What moves it is rarely the feature list. It is reminder tuning, the patient helpdesk answering in the patient's own language, and site coordinators seeing drift early enough to phone someone. All three are operational costs rather than build costs, which is why a platform funded without them tends to produce the same compliance figure as the vendor system it replaced, at higher total cost. Budget the operations alongside the software or the comparison will not hold up a year later.

Ongoing costs that never appear in a software quote

• Maintenance plus revalidation: 20 to 26 percent of build cost per year. Operating system updates on patient devices arrive whether you are ready or not, and each one needs a compatibility pass on a regulated system.
• Instrument licence fees. Quoted per study by the instrument owner, payable regardless of platform. Get these quoted before you compare build against licence, because they are frequently a larger number than either.
• Device fleet logistics. Per patient, per study: provisioning, shipping, connectivity, retrieval and wipe. This is a real per-head cost and it belongs in the study budget rather than the technology budget.
• Patient helpdesk. Patients call, in their own language, at inconvenient hours. Whether you staff it or outsource it, it is a recurring cost proportional to enrolment, and skipping it shows up immediately as falling compliance.
• Translation maintenance. Instrument revisions and new languages both trigger fresh approval cycles, and each one is calendar time as well as money.

When you should not build this

Do not build for one pivotal trial with a licensed primary endpoint instrument. Signant Health, Medidata Patient Cloud, YPrime and their peers have already done the migration and approval work for the common instruments, and that prior work is genuinely worth paying for when your filing depends on it. Taking on first-time screen approval for a validated instrument while a pivotal study is enrolling is a schedule risk with no compensating benefit.

The build case appears when you run a repeating instrument set across many studies and per-study configuration fees have become your largest data collection line, or when your endpoints combine questionnaires with sensor data in ways the packaged vendors quote heavily to support. Both are portfolio arguments. Before funding one, add up three years of actual per-study eCOA configuration spend, add the instrument licence fees you will pay either way, and compare that against build plus 20 to 26 percent annual maintenance.

If you want a second opinion before signing anything, Digital Heroes starts every engagement with a signed specification covering the data model, permissions and acceptance criteria, which is what keeps a fixed price fixed. The document is yours whichever way you go.